StockData
Novartis AG logo

Novartis AG (NVS) stock

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$159.13−1.07 (-0.67%)

Close on Nov 17, 2026Market cap $303.64BP/E 22.3Yield –

Novartis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Novartis's pe ratio was 22.8× on Nov 10, 2026, against 22.2× a year earlier. Over the last 5 years it ranged from 7.2× to 33.1×, with a median of 20.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 202622.8×−0.7
2025Dec 31, 202523.5×+9.8
2024Dec 31, 202413.7×−18.1
2023Dec 29, 202331.9×+23.3
2022Dec 30, 20228.5×−16.3
2021Dec 31, 202124.8×+6.2
2020Dec 31, 202018.7×+1.1
2019Dec 31, 201917.6×−8.8
2018Dec 31, 201826.4×−3.6
2017Dec 29, 201730.0×+20.0
2016Dec 30, 201610.0×–

More Novartis figures

See a number that looks wrong?